Gujarat Inject Kerala Ltd, a leading pharmaceutical company, has announced a robust financial performance for the fiscal year 2025-26 (FY26), with net profit surging 78% year-on-year. The company's net profit stood at INR 45.2 crore, compared to INR 25.4 crore in the previous fiscal year, driven by strong operational efficiencies and increased demand for its products.
Key Financial Highlights
The company's revenue from operations grew by 22% to INR 320 crore in FY26, up from INR 262 crore in FY25. This growth was primarily fueled by higher sales in the domestic market and a steady increase in export orders. The earnings before interest, taxes, depreciation, and amortization (EBITDA) margin improved to 18.5%, reflecting better cost management and economies of scale.
Segment Performance
The injectables segment, which contributes the largest share to the company's revenue, saw a 25% growth, driven by new product launches and expanded distribution networks. The company also reported a significant reduction in debt, with net debt declining by 30% to INR 60 crore, strengthening its balance sheet.
Management Commentary
Commenting on the results, the Managing Director of Gujarat Inject Kerala Ltd stated, "We are delighted with our FY26 performance, which reflects our commitment to operational excellence and innovation. The 78% growth in net profit is a testament to our strategic initiatives and the hard work of our team. We remain focused on expanding our product portfolio and enhancing our manufacturing capabilities to drive sustainable growth."
Outlook
Looking ahead, the company expects continued growth momentum, supported by a strong pipeline of products and increasing demand from both domestic and international markets. The management has guided for revenue growth of 18-20% in FY27, with further margin improvements anticipated. The company is also investing in capacity expansion to meet future demand.
Gujarat Inject Kerala Ltd has been a key player in the pharmaceutical injectables space, known for its high-quality products and robust distribution network. The strong FY26 performance positions the company well for future growth in a competitive industry.
